AngioDynamics Inc. (ANGO)
NASDAQ: ANGO
· Real-Time Price · USD
10.59
-0.13 (-1.21%)
At close: Sep 25, 2025, 3:59 PM
10.59
0.00%
After-hours: Sep 25, 2025, 04:33 PM EDT
-1.21% (1D)
| Bid | 10.3 |
| Market Cap | 430.31M |
| Revenue (ttm) | 292.5M |
| Net Income (ttm) | -33.99M |
| EPS (ttm) | -0.83 |
| PE Ratio (ttm) | -12.76 |
| Forward PE | -34.81 |
| Analyst | Buy |
| Dividends | n/a |
| Ask | 11.22 |
| Volume | 373,543 |
| Avg. Volume (20D) | 536,636 |
| Open | 10.70 |
| Previous Close | 10.72 |
| Day's Range | 10.40 - 10.75 |
| 52-Week Range | 5.83 - 13.50 |
| Beta | 0.64 |
| Ex-Dividend Date | n/a |
About ANGO
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ANGO
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ANGO stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsAngioDynamics Inc. is scheduled to release its earnings on
Oct 2, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
-10.18%
ANGO stock has given up its prior gain. AngioDynam...
Unlock content with
Pro Subscription
2 months ago
-10.18%
AngioDynamics shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY26 revenue guidance above estimates.
1 month ago · seekingalpha.com
AngioDynamics: A MedTech Powerhouse Emerging From Legacy OverhaulAngioDynamics has completed a strategic transformation, divesting non-core assets and focusing on high-growth MedTech platforms, driving accelerating revenue and margin improvement. Recent results con...
